XyloCor Therapeutics
Series B
Gene therapy for cardiovascular diseases
XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.
Founders
R
LinkedIn
News & Funding
Similar Startups
Centivax
Broad-spectrum vaccine
Latent
Series A
Medical language models for healthcare overhead
Celularity
Biotech cellular medicines
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Freenome
Blood test to detect colorectal cancer
Honest Health
Primary care for senior care